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POPULAR SCIENCE SUMMARY OF THE THESIS 
 
Can sound waves make your bones grow longer? 
Each individual varies considerably in height, and this can be attributed to differences in the 
function of the growth plate, a specific structure located at each end of our long bones. The 
growth plate is very active until adolescence and is then gradually replaced by bone whereafter 
we no longer can grow. Any damage/injury to the growth plate before closure can lead to 
abnormal bone growth or leg length difference. Existing operating and medical ways to correct 
such abnormalities are effective but may have different side-effects. In this thesis project, I 
have studied if a type of sound waves (shock waves) can be used to stimulate growth plate 
cartilage from animals and humans and if bone growth can be accelerated in different animal 
models. In rat and rabbit bones, sound waves increased the bone length after treatment by 
activating different genes responsible for bone growth. When the growth plate cells were 
damaged, shock wave treatment was found to prevent them from dying. In human growth plate 
tissue, shock wave treatment was found to increase gene markers required for bone elongation. 
In the future, encouraging results from this study may help us find a new method to treat leg 
length difference, avoiding the known side-effects of existing surgical techniques. 
  
ABSTRACT         
Aim: The overall aim of this thesis was to investigate the potential for radial shock wave 
treatment (rSWT) to regulate growth plate chondrogenesis and longitudinal bone growth. It 
was based on the hypothesis that the effects are dose-dependent in a bimodal response pattern 
where low-energy rSWT will increase chondrocyte proliferation/hypertrophy, and thereby 
bone growth, while high frequency/energy rSWT will induce chondrocyte apoptosis and 
thereby, premature growth plate closure. 
Methods: To achieve this, we experimentally studied the role of rSWT in three different model 
systems: in vitro cultures of a mouse chondrocytic cell line, in ex vivo organ cultures of fetal 
rat metatarsal bones and human growth plate cartilage, as well as in vivo in rabbits. 
Results: A single session of high-energy rSWT was capable of locally promoting longitudinal 
bone growth in rat metatarsal bones cultured under normal physiological conditions. Detailed 
immunohistomorphometric analysis of sectioned growth plate cartilage revealed that this 
stimulatory effect was linked to augmented chondrocyte proliferation and hypertrophy, and 
decreased apoptosis. Furthermore, mechanistic studies of molecular markers governing growth 
plate chondrogenesis showed increased expression of PTHrP, GLI-1, NFkB, and IGF-1 in the 
bones exposed to rSWT (Paper I). Next, we investigated  the role of rSWT in an ex vivo model 
of growth impairment where Hh signaling was blocked. Cultured fetal rat metatarsal bones 
were challenged to two different Hh inhibitors, vismodegib and GANT61, causing growth 
retardation, while when combined with a session of rSWT the inhibitory effects on growth 
plate chondrogenesis and bone growth were partially abrogated (Paper II). Thereafter, we 
performed in vivo studies in immature and adolescent rabbits and observed that high-energy 
rSWT increased the formation of chondrocyte columns and longitudinal bone growth, 
respectively (Paper III). Finally, mechanistic studies revealed that rSWT caused upregulation 
of chondrogenic genes  when studied in a unique model of cultured human growth plate 
cartilage (SOX9, GLI-1, IHH, COL-X, and IGF-1) and also in the mouse ATDC5 chondrocytic 
cell line (Acan, Sox9 and, Col2a1) (Paper IV).  
Conclusion: Altogether, our observations, verified in preclinical and in vitro models, propose 
that high-energy radial shockwave treatment could potentially be used to stimulate growth plate 
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If I have a thousand ideas and only one turns out to be good, I am satisfied, said Alfred Nobel.  
All scientific discoveries lead to something, and some are truly groundbreaking. I have always 
believed that most of the research questions that involve a basic understanding of cellular origin 
and function have been attempted in the yesteryears with limited technology and resources that 
were available then. Based on the historic leads built from the past, we are now refining our 
knowledge by using cutting-edge technology. The research question asked in this thesis is no 
exception to this statement. I would say that the groundwork for the current study was established 
in the 1980s.   
At the beginning of this current research, shock wave technology was already an established 
clinical therapy in children with musculoskeletal disorders. Also, in one of my institutions, it was 
started as a new therapy for children with muscle spasticity. Based on the very few existing 
preclinical studies, shock wave treatment is deemed to be contraindicated in young growing 
children. It is therefore understood that it should not be used in the area around the knee and near 
growing physis. Therefore, before proving its efficacy on repairing spastic muscle, the effect of 
shock wave treatment on physeal cartilage needs to be evaluated. This observation was the 
foundation and motivation for us to carry out the present study and expand the knowledge to 
understand if shock wave therapy can be used as a potential non-invasive modality to regulate 
bone growth in children. During the study proposal, the hypothesis was expanded wherein a 
positive or negative effect on growth could be harnessed for therapeutic growth modulation while 
no change establishes safety. In addition to being of interest to both endocrinologists and 
orthopedic surgeons, another motivation and relevance for this collaborative study was that the 
children in India are short-statured while those in Sweden are extremely tall-statured.  
In the subsequent sections, I have outlined the basics of longitudinal bone growth, the relevance 
of shock wave therapy in this context, how the present study complements the pioneering studies 










2 LITERATURE REVIEW 
One of the unique aspects of longitudinal bone growth is the presence of the growth plate (or 
physis) that is sandwiched between the epiphyseal and metaphyseal region of a long bone. Bone 
growth is majorly dependent on the interaction of many hormonal, local growth factors, as well 
as mechanical factors. As the growth plate cartilage in children is delicate, it is more susceptible 
to injuries due to acute trauma. Other etiologies leading to premature growth impairment or 
abnormal growth include tumors, infections, and genetic mutations, or hormonal deficiencies 
(Nilsson, 2018; Peters, Irving, & Letts, 1992; Shapiro, 1982; Stanton & Abdel-Mota'al, 1998; 
Wilson & Thompson, 1939).  
An altered growth followed by a deformity can also result from abnormal mechanical loading. 
This phenomenon also referred to as mechanical modulation of bone growth, has significant 
implications in the progression of various congenital musculoskeletal deformities such as genus 
varus/valgus, tibia vara/valga, and limb length discrepancy (Aitken, 1976; Scheffer & Peterson, 
1994). Surgical management of such deformities is focused on altering the mechanical 
environment of deformed bones. For instance, external fixators are attached to the bone for limb 
lengthening, while eight plate screws are applied to the growth plate to slow down bone growth. 
However, there is a limited basic understanding of how mechanical forces regulate bone growth.  
This review of published work and my own experience summarizes the current state of research 
concerning critical questions about the underlying mechanisms of biomechanical mediated bone 
growth. I have discussed growth plate chondrocyte mechanobiology, how it contributes to bone 













2.1 NORMAL PHYSEAL ANATOMY   
2.1.1 Gross 
All long bones (clavicle, humerus, radius, ulna, femur, tibia, and fibula) have growth plate 
cartilage at both ends whereas smaller bones (metacarpals, metatarsals, and phalanges) have a 
physis at one end only. During various phases of postnatal growth and development, a secondary 
ossification center (SOC) appears within the epiphysis (Kronenberg, 2003). The secondary 
ossification center persists until the closure of the growth plate and aids to demarcate the physeal 
zone on the radiographs. Recent evidence suggests an evolutionary reason behind the onset of 
SOC, where it acts as a shielding structure to protect the weakest region of the growth plate 
cartilage from high mechanical stress (Xie et al., 2020). In humans, the overall growth rate 
decelerates until skeletal maturity at the end of the early pubertal stages, despite pubertal growth 
spurts during the adolescence period.  
2.1.2 Microscopic  
The histological architecture of the growth plate is well-organized and relevant to understand the 
concept of linear bone growth. Conventionally from the center of the epiphysis to the metaphysis, 
the growth plate cartilage is divided into four zones: resting (germinal), proliferative, 
hypertrophic, and calcification (Emons, Chagin, Sävendahl, Karperien, & Wit, 2011; Kirkwood 
& Kember, 1993). The chondrocyte proliferation is localized to the resting and proliferative 
zones, whereas the remaining two zones are categorized by the hypertrophic chondrocytes, 
matrix production, cell death, and calcification. The process by which longitudinal bone growth 
occurs primarily by the transformation of cartilage to the bone is termed endochondral 
ossification (Kember & Sissons, 1976). It contrasts with the appositional bone growth where the 
mesenchymal progenitor cells in the periosteum are directly converted to osteoprogenitors via 
intramembranous ossification (Debnath et al., 2018). The zone of Ranvier consists of the 
fibroblasts, chondroblasts, and osteoblasts and responsible for increasing the width of the bone 
(Rockwood, 2010). The perichondrial ring on LaCroix imparts mechanical stabilization of 
epiphysis to the metaphysis. Although the growth plate is considered avascular, the epiphysis 
and SOC receive their blood supply that enters through the perichondrium to remain active 
(Trueta & Morgan, 1960). To allow the normal process of bone development, there exists an 
inherent genetic switch that regulates the differential growth processes. These adaptations vary 
between species as the bone growth rate is connected to the number of cells distributed in each 
of the growth plate zones (Kirkwood & Kember, 1993) (E. B. Hunziker, 1994) (E. Hunziker, 






The proportion and the number of chondrocytes present within the growth plate zones vary 
relatively between different species (Figure 1). For instance, avian and human growth plates 
have a more expansive resting zone (Farnum & Wilsman, 1998). Sergerie et al. (2009) has 
quantified the contribution of resting, proliferative and hypertrophic zones in neonatal ulnar 
porcine growth plates to be 70%, 17%, and 13%, respectively (Sergerie, Lacoursière, Lévesque, 
& Villemure, 2009). In contrast, in 3-weeks-old proximal tibiae rat growth plates, the 
corresponding zones were 6%, 35%, and 59% (E. Hunziker & Schenk, 1989). Since the long 
bone growth is directed away from the proliferative zone, the growth plates are considered 
monopolar. These are unlike the iliac apophyseal growth plates (bipolar) where growth occurs 
bidirectionally with resting chondrocytes in the middle, and proliferative and hypertrophic 
chondrocytes on both sides (Villemure & Stokes, 2009). 
 
Figure 1. Gross and differences in the histological architecture of the growth plate zones across 
species. a. Fetal rat metatarsal bones; b. Rabbit distal femur; c. Goat proximal tibia; and d. Human 
proximal tibia. White interrupted lines indicate the growth plate cartilage. Note the differences in the 
cellularity, organization of the column, as well as the thickness in the resting zone (RZ), proliferative zone 
(PZ), and hypertrophic zone (HZ). A schematic picture of the growth plate architecture and key intrinsic 
signaling pathways in each growth plate zone (right). The illustration represents the different cellular 
zones; epiphyseal and metaphyseal bone on each end of the growth plate contains blood vessels that supply 





2.2 WHAT ARE THE FACTORS INFLUENCING BONE GROWTH?  
2.2.1 Hormonal regulation of growth plate cartilage 
Growth hormone (GH) and insulin-like growth factors (IGFs) in the systemic circulation 
effectively stimulate bone growth (Figure 2). A breakthrough study by Olle Isaksson more than 
30 years ago found that local injection of growth hormone directly stimulates growth plate 
cartilage and local production of IGF-1 (Isaksson, Jansson, & Gause, 1982). Preclinical studies 
have shown intrauterine and postnatal growth retardation in mice lacking the igf (Baker, Liu, 
Robertson, & Efstratiadis, 1993) and GH genes (Zhou et al., 1997), respectively. An imbalance 
of the GH/IGF-1 axis due to other factors also influences final bone length. The presence of 
excess glucocorticoids leads to decreased growth rate in humans (Allen, 1996) and animals 
(Altman, Hochberg, & Silbermann, 1992; Chrysis, Ritzen, & Sävendahl, 2003). Thyroid 
hormone and sex steroids contribute to accelerated bone growth and the prepubertal growth spurt 
(Kindblom et al., 2001; Nilsson, Marino, De Luca, Phillip, & Baron, 2005). Estrogens directly 
stimulate the pituitary gland to release GH. Growth hormone is secreted in a pulsatile manner 
during childhood, and during puberty under estrogen stimulation, there is an increased burst of 
GH, and this drives IGF-1 production, primarily from the liver. Estrogens also have direct effects 
on the growth plate, stimulating growth plate fusion. In a male patient, Eric Smith in 1994 made 
a breakthrough discovery showing that a mutation in estrogen receptor alpha prevented growth 
plate fusion to occur highlighting the crucial role of estrogen action for this important process 
(Smith et al., 1994).  
 
Figure 2. Hormonal regulation of growth plate cartilage. A schematic representation of the local and 
systemic actions of the GH/IGF-1 axis on longitudinal bone growth. The illustration represents the 
essential signaling pathway in which GH and IGF-1 influence longitudinal bone growth. Apart from 
stimulating IGF-1 production in the liver, GH also stimulates growth plate via local secretion of IGF-1 in 
growth plate chondrocytes. The red symbol indicates the negative feedback mechanism of IGF-1 
inhibiting GH synthesis and release.  
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2.2.2 Local regulation of growth plate cartilage 
The resting zone of the growth plate is the region adjacent to the ossifying epiphysis. With a 
round morphology, these cells possess a high matrix synthesis to cell volume ratio with relatively 
low mitotic activity (quiescent state). A transcription factor, SOX-9, is responsible for 
maintaining chondrocytes in their native phenotype and synthesizing its associated matrix for 
survival (Leung et al., 2011). It is followed by the zone of proliferation which is identified by 
longitudinal columnar-like appearance. As early as 1987, Brighton et al. put forward a theory 
that the resting chondrocytes do not contribute directly to the growth process. He hypothesized 
that the proliferative chondrocytes that exist closest to the resting zone are stem-cell-like and that 
upon cell division, the upper daughter cells may continue to be stem-cell-like while the lower 
daughter cell contributes to proliferation (Brighton, 1987). While later in 1994, Hunziker 
postulated that the resting chondrocytes might serve as the hub for stem-cell-like cells, divide 
only upon a stimulus and continue to repopulate upon division (E. B. Hunziker, 1994). The latter 
hypothesis was supported by Abad et al. in 2002 when he demonstrated that chondrocytes in the 
resting zone alone could replenish the proliferating and hypertrophic zone in a rabbit model 
(Abad et al., 2002). More recently, two studies back-to-back provided compelling evidence using 
the confetti mice model that indeed the resting zone houses stem-like cells (Mizuhashi et al., 
2018) and are positive for stem cell marker, CD73 (Newton et al., 2019). It is indeed very 
intriguing to see how the mystery of growth plate biology has unraveled over the years.  
In the proliferative zone, cells begin to multiply and have a flattened phenotype; the matrix is 
enriched with collagen type II, IX, and XI. Around nine decades ago, Dodds proposed that the 
columnar arrangement of the cells is driven via chondrocyte rotation. Cell division occurs by 
assuming a compressed phenotype along the mediolateral axis, rotating 90° and stacks on top of 
each other such that it is proximodistal to the axis of the long bones (Dodds, 1930). While growth 
plate flipping experiments in rabbits, suggest that resting cells secrete morphogens to orient them 
in this manner (Abad et al., 2002). More recently, it has been shown that the mechanical forces 
via the organization of the actin cytoskeleton (Killion, Mitchell, Duke, & Serra, 2017) and 
noncanonical frizzled signaling acting on the growth plate cartilage (Li & Dudley, 2009), 
together regulate chondrocyte polarity. Although the columnar arrangement of chondrocytes is 
conserved across species, there is a striking difference in their mitotic activity. One proliferating 
chondrocyte in a 4-week old rat takes about 48 hours to complete its cell cycle in contrast to 
human (5-8 years of age) chondrocytes where it spends 20 days (E. Hunziker & Schenk, 1989; 
E. Hunziker et al., 1987; Kember & Sissons, 1976). Every new proliferative chondrocyte that is 
produced contributes to an increase in growth plate height equivalent to its height, approximately 
7 µm (E. B. Hunziker, 1994). This rate of chondrocyte proliferation is controlled locally by 
several paracrine factors such as parathyroid hormone-related peptide (PTHrP), Indian hedgehog 




The region, at which cell division terminates and is accompanied by swelling of their lacunae is 
termed as the hypertrophic zone. It is marked by an increase in type X collagen (COL-X) 
expression and identified by the presence of blood vessels, osteoclasts, osteoid, woven bone, and 
osteoblasts. It is considered a significant contributor to long bone growth. A new hypertrophic 
chondrocyte takes only about 9 hours to contribute to an 8 µm increase in bone length and up to 
20% increase in growth rate may be achieved by selectively modulating the cells in this zone (E. 
Hunziker & Schenk, 1989).  
The overall process of endochondral ossification is believed to be mediated either by classical 
apoptosis where osteoblasts invade the chondrocytes, hypertrophic chondrocytes 
transdifferentiate into osteoblasts, hypoxia (low oxygen), or autophagy (Emons et al., 2011). 
Each paradigm mentioned above is still a subject of debate in the process of epiphyseal fusion. 
It has been shown that when an individual approaches skeletal maturity, there will be an 
exhaustion of resting chondrocytes and a significant reduction in cell proliferation and division 
(Schrier et al., 2006). Histomorphometric studies of the growth plate also support this finding 
where growth plate fusion is accompanied by structural changes (Alexander, 1976; Kember & 
Walker, 1971).  Some of the essential endocrine factors that influence bone elongation are GH, 
IGF-1, steroid hormones (estrogen and androgen), thyroid hormone and glucocorticoids 
(Sävendahl, 2005; Weise et al., 2001). Thus, coordinated action of both paracrine and endocrine 
factors is indispensable for the regulation of linear bone growth. 
2.3 CLINICAL CONDITIONS WITH GROWTH FAILURE 
Technological advances in the recent past have been possible due to laser microdissection, small 
RNA sequencing, tissue-specific gene targeting in mice, and genetic screening of rare diseases. 
As we now understand that the growth plate is tightly regulated by paracrine and endocrine 
signaling pathways to function normally, mutations in the genes underlying these signaling 
cascades lead to abnormal growth and present as a skeletal deformity. Some of the clinical 
conditions are listed in Table 1. 
Table 1. Clinical conditions due to impaired chondrogenesis 
Defects in the early stages of chondrogenesis 
Defects in the local 
growth factors 
Heterozygous mutations in SOX9 Campomelic dysplasia              
(Kwok et al., 1995) 
Defects in late stages of chondrogenesis 
 
Defects in the local 
growth factors 
Inactivating mutations in its receptor 
(PTH1R) result in Blomstrand 
dysplasia 
Blomstrand dysplasia        
(Duchatelet, Ostergaard, Cortes, 
Lemainque, & Julier, 2004) 
Homozygous mutations in IHH gene Acrocapitofemoral dysplasia 
(Hellemans et al., 2003) 
Heterozygous mutations in Runx2 Cleidocranial dysplasia (Otto, 
Kanegane, & Mundlos, 2002) 
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2.4 SURGICAL INTERVENTION FOR GROWTH MODULATION 
2.4.1 Growth stimulation 
Alessandro Codivilla was the first to introduce the surgical technique for bone lengthening in 
1905. By applying stepwise traction, lengthening can be achieved (Codivilla, 1905). Later in 
1951, Ilizarov applied the principle of distraction osteogenesis to treat a wide range of conditions 
such as nonunions, congenital deformities and bone shortening (Codivilla, 1905). This method 
uses an external fixator with two ring blocks compressed together. The bone and soft tissue are 
distracted at a rate of 1 mm per day divided into four parts; patients between 13 and 15 years of 
age and height between 110-150 cm are suitable for the procedure. More recently, computer-
assisted circular frames such as the Taylor Spatial Frame have gained a lot of attention. The next 
step in the evolution of this technique was the use of a self-distraction motorized nail that 
magnetically drives the titanium intramedullary complications to overcome the complications of 
the external fixation (Green, 2017). However, Ilizarov is still considered as a gold standard for 
all limb lengthening procedures. Though the technique is effective in improving the growth, it is 
time-consuming and often associated with reduced range of motion in Achilles tendon post-
surgery. Other common complications include pin-tract infections, poor regeneration, and axial 
malalignment (Paley, 1990).  
2.4.2 Growth arrest 
Epiphysiodesis, introduced by Phemister in 1933, is a surgical method by which growth plate 
cartilage is destroyed to restrict longitudinal bone growth (Phemister, 1933). The technique has 
evolved over the years and is considered safe in significant growth reduction (Benyi et al., 2010; 
Canale, Russell, & Holcomb, 1985). A reduction in height by about 4-7 cm after bilateral 
percutaneous epiphysiodesis has been reported (Benyi et al., 2010; Odink et al., 2006). Also, for 
the treatment to be effective, the recommended age for surgery is before bone age 12.5 years in 
girls and 14 years in boys (Benyi et al., 2010). Reversible methods of epiphysiodesis include 
physeal stapling, guided growth plates (8 plate, peanut plate of Biomet). The risk of infection and 
the possibility of skeletal deformities, including leg length differences are, however, the 








2.5 NON-SURGICAL INTERVENTION FOR GROWTH MODULATION 
2.5.1 Growth stimulation 
Human growth hormone has been used in the treatment of GH-deficient children for more than 
3 decades (Gharib et al., 2003; P. A. Lee et al., 2012). It aims at promoting linear growth and 
stopped after the fusion of the physis (Novikov, Subramanyam, Muradisinov, Novikova, & 
Kolesnikova). Though rGH therapy improves linear bone growth, the safety of the treatment has 
always been a concern. A recent study has evaluated the long-term safety (15 years) in GH-
treated patients. The outcome suggests that there is no relationship between GH dose and the 
occurrence of adverse events in patients receiving rGH therapy (Sävendahl et al., 2020; 
Sävendahl, Pournara, Pedersen, & Blankenstein, 2016). Another concern is the risk of cancer 
associated with hormonal therapy. This was addressed by the SAGhE European cohort study 
where no relation between the duration or dose of GH therapy and the risk of cancer was 
observed. However, those patients treated after previous cancer had an increased risk of cancer 
with increasing GH dose (Swerdlow et al., 2017). These data suggest further long-term follow-
up in patients with no history of malignancy, as the manifestation is more common in the older 
population (e.g. prostate cancer). 
2.5.2 Growth arrest 
Non-surgical treatment for height reduction includes sex steroid therapy which has been in 
practice since 1956 for girls (Goldzieher, 1956) and 1998 for boys (Drop, De Waal, & de Muinck 
Keizer-Schrama, 1998). Though considered to be effective in reducing growth (de Waal, 1996), 
safety is still a matter of concern. In contrast to the testosterone treatment, estrogen therapy in 
girls is associated with a reduction in fertility as a long-term side effect (Hendriks et al., 2011; 
Venn et al., 2008). Also, reports suggest an increased incidence of melanoma with high-dose 
estrogen treatment (Benyi et al., 2014). Some of the other hormonal therapies include 
somatostatin (Hindmarsh, Pringle, Stanhope, & Brook, 1995) and bromocriptine (Brion, 








2.6 BIOMECHANICAL STIMULATION OF BONE AND GROWTH PLATE 
CARTILAGE 
Bones undergo continuous remodeling depending on the adjacent mechanical microenvironment. 
A German surgeon Julius Wolff in 1893 put forth a law that a bone tissue subjected to mechanical 
lading will regenerate and those not subjected to stress will atrophy. This states that the bone 
density will depend on its stress conditions. While the biomechanical influence on linear bone 
growth is regulated by Heuter-Volkmann law where increased mechanical compression results 
in growth retardation while reducing loading accelerates growth (Villemure & Stokes, 2009).   
2.6.1 Mechanotherapy at the molecular level 
Chondrocytes and osteocytes respond well to mechanical cues. Several cell-signaling pathways 
have been identified as targets in response to mechanical stimuli. Some of the key players in bone 
repair and formation include intracellular calcium ion signaling, prostaglandin and nitric oxide 
(NO) signaling, and Wingless-type (Wnt)/β-catenin signaling (Huang & Ogawa, 2010). Integrin 
signaling, TGF-β/Smad, mitogen-activated protein kinase (MAPK) signaling, Rho-associated 
protein kinase (ROCK) signaling, tumor necrosis factor-α (TNF-α)/nuclear factor-kappa light-
chain-enhancer of activated B cells (NF-κB) signaling, and Wnt/β-catenin pathways are involved 
in treating disorders with abnormal fibroblast proliferation (Huang & Ogawa, 2012). By 
selectively targeting these signaling molecules using specific inhibitors, it may be possible to 
reverse the disease phenotype of the cells to treat a disease.  
At the most superficial level, mechanotherapy alter the signal transduction by controlling one of 
the following stages: (i) mechanocoupling phase, where the exerted mechanical signal perceived 
by the mechanosensors of the cell; ii) biochemical coupling, where the mechanical signal is 
translated into a biological signal, a language that is understood by the cells eventually leading 
to changes in transcription factors and protein expression; (iii) signal transmission, where the 
biological signal from the receiver cell is transferred to the effector cells leading to activation of 
signals in different cell types; (iv) cellular response, where there is an overall change in the gene 
expression pattern (Figure 3) (Huang, Holfeld, Schaden, Orgill, & Ogawa, 2013; F.-Y. Lee et 




Figure 3. Phases of mechanotransduction following mechanical stimulus: 1. Mechanocoupling, 2. 
Signal transduction, 3. Activation of neighboring cells and 4. Matrix synthesis. Source: Adapted and 
modified from (Huang et al., 2013).  
2.6.2 Mechanotherapy at the cellular level 
Some of the neurodegenerative and growth plate defects conditions result in cellular dysfunction 
by affecting the cytoskeleton (McGlashan, Haycraft, Jensen, Yoder, & Poole, 2007; McMurray, 
2000). Integrin-mediated cellular function that affects cytoskeletal components is of great 
interest. Other mechanosensors including cell junctions, connexins, primary cilia, and sensory 
ion channels, are important. Specific fundamental changes in mechanotransduction include 
changes in the extracellular matrix proteins, stretch-activated ion channels, glycocalyx, cell-cell 
receptors, cytoskeletal components, nucleus, cytoplasm and mitochondria. 
2.6.3 Mechanotherapy at the tissue level 
Mechanotherapies targeting the tissue level are mainly focused on improving wound healing, and 
these include micro-deformational wound therapy, extracorporeal shockwave therapy (ESWT), 
soft tissue expansion, callus distraction, and surgical tension reduction (Huang et al., 2013). The 
other non-invasive mechanotherapy strategies for growth modulation such as radiofrequency 
ablation, mechanical loading, ultrasound, and low-level laser therapy are under different phases 
of preclinical investigations with minimal effect on growth. The subsequent section will only 
focus on shock wave therapy as it is more relevant to the topic of discussion.  
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2.7 SHOCK WAVE TECHNOLOGY 
Mechanotransduction is a cellular process of converting mechanical stimuli into a biological 
response. Shock wave treatment exerts a mechanical force on the cellular components. The 
transient changes include alteration in the cytoskeleton, cellular adhesion and cell migration 
while long-term effects are mediated through regulation of different signaling pathways and 
molecular processes (d'Agostino, Craig, Tibalt, & Respizzi, 2015).  
A shock wave is a short acoustic wave possessing energy and travelling in a three-dimensional 
space (Ogden, 2006). It is generated when the speed of the source exceeds the speed of the sound 
(e.g. a lightning strike). These waves are characterized by a discontinuous pattern in the medium 
they propagate; associated with a rapid increase in pressure and temperature. The strength of a 
shock wave is inversely proportional to the distance from the source. It is represented as a single 
positive pressure pulse, followed by a small negative pulse. The frequency varies from a few 
kilohertz to 10 MHz Unlike ultrasound, the shock wave pattern differs in having a high-pressure 
amplitude and single pulse. This concept was modified and adapted in the field of medicine. They 
can be either focused or radial waves. The differences between the two patterns are based on its 
wave characteristics are given in Table 2 (Maier et al., 2002).  
 
Table 2. Physical characteristics of shock waves generated by different mechanisms. 
 
Characteristics 




Pneumatic ballistic  
(Radial ESWT) 
Pressure 200-800 bar (20-80 MPa) 4-5 bar (0.4-0.5 MPa) 
Pressure rise time 0.01 μs 50 μs 
Speed of shock wave 1500 m/s 20 m/s 
Duration of positive pulse <1 μs 200 μs 
Energy flux density High energy 0.27-0.60 mJ/mm2 
Low energy 0.08-0.23 mJ/mm2 
0.17 mJ/mm2 
Penetration depth 80-140 mm 30-35 mm 
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2.8 SHOCK WAVE THERAPY FOR MUSCULOSKELETAL DISORDER: A 
SERENDIPITOUS EVENT?  
Extracorporeal shock wave therapy (ESWT) was first used in 1980 for kidney stone 
disintegration (Chaussy, 1988).  In the late 1990s, Haupt was the pioneer in reporting the effect 
of shock waves on the bone (Haupt, 1997). Subsequently, many clinical orthopedic conditions 
have been treated, including Achilles tendinopathy (Furia, 2006), lateral epicondylitis of the 
elbow (Ko, Chen, & Chen, 2001) and calcifying tendinitis of the shoulder (Loew, Daecke, 
Kusnierczak, Rahmanzadeh, & Ewerbeck, 1999). However, a shock wave machine exclusively 
designed for orthopedic use was first introduced in 1993. It is now considered as a novel 
therapeutic modality as it eliminates surgical risks and pain. Since then, it has led to the treatment 
of various musculoskeletal disorders (Haupt, 1997). The technology was further refined by the 
year 2000 when radial shock wave treatment (rSWT) was introduced exclusively for superficial 
musculoskeletal conditions (Fig.1). More specifically, rSWT is effectively used in many centers 
to treat spastic muscles in children with cerebral palsy (Gonkova, Ilieva, Ferriero, & Chavdarov, 
2013). Though recent studies have shown the ESWT treatment to be effective and safe in Osgood 
Schlatter or Sever’s disease (Lohrer & Nauck, 2015; Lohrer, Nauck, Schöll, Zwerver, & 
Malliaropoulos, 2012), it is essential to note that ESWT must be used with caution if applied 
close to the growth plate and therefore is still not recommended in the pediatric population.  
2.8.1 Clinical evidence for treating muscle spasticity 
Cerebral palsy (CP) is a manifestation of a damaged motor neuron during brain development. 
Children with spastic CP have passive muscle stiffness (high collagen content) which in turn 
leads to muscle atrophy, muscle weakness and shortening. Botulinum toxin (BTX), passive 
stretching, serial plastering, and splints are the conventional treatment of spasticity (Hoare et al., 
2010; Tedroff, Löwing, Haglund‐Åkerlind, Gutierrez‐Farewik, & Forssberg, 2010). Though 
BTX is effective in treating muscle spasms, it still has local side effects such as swelling at the 
injection site, common cold, etc. As a non-invasive option, radial shock wave treatment has been 
shown to produce a long-lasting reduction in spasticity without any side effects. A randomized, 
placebo-controlled trial, showed that the therapeutic effect on severe spastic upper- and lower-
limbs lasted up to 2 months post-treatment within three sessions of ESWT (2,000 impulses, 0.10 
mJ/mm2) (Vidal, Morral, Costa, & Tur, 2011), while other studies applying a single session of 
ESWT on plantar flexor muscle was effective up to 4 weeks (Amelio & Manganotti, 2010)  
(Gonkova et al., 2013). The mechanism by which ESWT decreases muscle spasticity could be 
by increasing the blood flow to muscles and unlinking the functional bonds between actin and 
myosin (Mirea, Onose, Padure, & Rosulescu, 2014). The secondary effect of ESWT on growing 
children still needs to be verified.  
 
18 
2.8.2 Clinical evidence for non-union fractures 
Focal ESWT is increasingly considered as the first choice of treatment for non-union fractures 
less than 5 mm in most of the European centers (especially in Germany). Table  3 summarizes 
the clinical dose for each long bone (Xu et al., 2009). 





A systematic review published in 2009 including ten studies concluded that an overall union rate 
after ESWT was around 72%; a larger randomized trial is necessary to better understand the 
clinical efficacy of ESWT on fracture healing (Petrisor, Lisson, & Sprague, 2009). While another 
recently published review (106 studies) suggests that 2000 impulses and an energy level that 
could be tolerated by the patient (three sessions at an interval of one week) are considered safe 
(Schmitz et al., 2015). Studies have also shown ESWT to be effective in alleviating pain and hip 
function in patients with early osteonecrosis of the femoral head, mediated through stimulation 
of angiogenic, osteogenic and anti-inflammatory factors (C.-J. Wang, Yang, & Huang, 2011).    
2.9 EFFECT OF SHOCK-WAVE TREATMENT ON ARTICULAR CARTILAGE AND 
BONE (ANIMAL STUDIES) 
A study in immature rabbits by Vaterlein et al. reported that application of shock waves at 2000 
impulses, 1.2 mJ/mm2 (Osteostar, Siemens) on the lateral femoral condyle did not induce any 
pathological changes or damage to the joint cartilage after 24 weeks (Väterlein, Lüssenhop, 
Hahn, Delling, & Meiss, 2000). Wang et al. studied the effect of low energy shock waves (200 
impulses, 0.095 mJ/mm2, DolorClast Master) on 36 rabbits with a full-thickness cartilage defect 
on the medial femoral condyle. Twelve weeks later, a progressive regeneration of hyaline-like 
cartilage in the shock wave treated group was observed (Q. Wang et al., 2011). In another study, 
36 rabbits were used to determine the effect of shock waves on healing at the tendon-bone 
interface; the healing rate was accelerated in the shock wave treated group. Some studies have 
also found rSWT to induce in vivo bone formation in rabbits after six weeks with 4000 impulses 
at 0.16 mJ/mm2 (2 sessions) (Gollwitzer et al., 2013). Attempts have also been made to 
understand the impact of shock waves on normal rabbit femurs where 1500 impulses, 0.5 
mJ/mm2, and 0.9 mJ/mm2 led to damaging side effects (periosteal reaction) ten days post-
treatment (Maier et al., 2002).  
Site of treatment Impulses Energy 
Lower limbs 6,000-10,000 0.62 mJ/mm2 
Humerus 4,000 0.56 mJ/mm2 
Radius and ulna 3,000 0.56 mJ/mm2 
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2.10 EFFECTS OF SHOCK WAVE TREATMENT ON GROWTH PLATE 
CARTILAGE 
As mentioned earlier, shock wave treatment in growing children has been a subject of interest 
and debate. After a study by Yeaman et al., where shortening of rat tibia at ten weeks after 
treatment (lithotripsy) was observed, the application of ESWT was regarded as contraindicated 
on open growth plates (Yeaman, Jerome, & McCullough, 1989). It is a well-established fact that 
animal studies do not necessarily reflect what happens in humans, especially while using rats as 
a model. The epiphyseal fusion differs between the two as the growth plates of the rat remain 
open throughout life in contrast to humans where it undergoes fusion during late adolescence. 
Table 4 summarizes the list of published studies so far discussing the effect of shock waves on 
growth plate cartilage. Of the eight studies, five-show no effect on growth plate cartilage and one 
study shows increased epiphyseal thickness; of the other two, one shows 1% increase in bone 
length while the other shows an average of 3 mm and 2.4 mm shortening of the tibia and femur, 
respectively. Notably, five of the studies have used a lithotripsy device and not the ESWT 
machine, which is specific for the orthopedic application. Altogether, it is still unclear if ESWT 
may affect growth plate cartilage and longitudinal bone growth. 
The outcome may vary depending on the type of shock wave machine used, the amount of 
energy/impulses/frequency at which the waves are delivered, the target growth plate and the 
animal model used. No extensive study has been performed to date to delineate the effect of such 















Table 4. List of published studies so far highlighting the effects of shock wave therapy on the growth 
plate in different animal models 
Animal model, dose Site Outcome 
Lithotripsy ESWT 
Sprague Dawley rats 
(n=15); 1500 impulses, 
20kV 
Proximal tibia No significant difference in growth plate thickness, 
33% (2/6) showed limb shortening (not significant) 
at 10 weeks post-treatment.                          
(Yeaman et al., 1989) 
New Zealand white rabbits 
(n=6); 1000 impulses, 
18kV 
Distal femur No effect on the growth plate and bone growth at 6 
months post-treatment.                                         
(Van Arsdalen, Kurzweil, Smith, & Levin, 1991) 
New Zealand white rabbits 
(n=30); 1000 or 4000 
impulses, 14/21/28 kV 
Proximal tibia No effect on growth plate at 6 weeks post ESWT.                                                               
(Giusti, Penteado, Santos, Alves, & Faloppa, 2005) 
New Zealand white rabbits 
(n=18); 800 impulses,  
0.32 mJ/mm2 
Proximal tibia No effect on growth plate  at 72 hours, 2 weeks, 
and 4 weeks post treatment.                     
(Nassenstein, Nassenstein, & Schleberger, 2004) 
New Zealand white rabbits 
(n=20); 1500/3000 
impulses, 0.6 mJ/ mm2 (3 
sessions, 1-week interval) 
Proximal tibia Both showed an increase in growth plate thickness; 
no change in bone length at 6 weeks post-treatment.                                              
(Ozturk, Bulut, Oztemur, Kaloglu, & Kol, 2008) 
Electromagnetic ESWT 
New Zealand white rabbits 
(n=18); 2000/4000 
impulses, 0.08 mJ/mm2 
Proximal tibia Valgus deformity (80%), no damage to physis and bone 
length at 3, 6 and 12 weeks post-treatment.    
(Lüssenhop, Seemann, Hahn, & Meiss, 1998) 
Piezoelectric ESWT 
New Zealand white rabbits 
(n=14); 1000/5000 
impulses, 100MPa at 1 Hz 
Femoral diaphysis 1% increase in bone length compared to control at 6 
weeks post-treatment.                                                
(Saisu et al., 2004) 
Radial ESWT 
Wistar albino rats (n=16); 
1500/3000 impulses,    
0.38 mJ/mm2, 1 Hz 
Knee At 8 months, no difference in bone length- Femur, tibia                                                                       






2.11 CELLULAR MECHANISMS INVOLVED IN TRANSDUCTION OF 
BIOPHYSICAL STIMULI 
Several studies have looked at the effects of ESWT at the cellular level to understand the process 
of mechanotransduction. The most widely used cell type is endothelial cells, and results suggest 
increased vascularity and nitric oxide production after treatment (Rohringer et al., 2014). Raabe 
et al. reported a positive outcome of ESWT on cell viability, proliferation and differentiation 
potential of adipose-derived mesenchymal stem cells (MSCs) derived from an equine model 
(Raabe et al., 2013). Shock wave treatment of human umbilical cord-derived MSCs 
(0.16/0.24/0.42 mJ/mm2 at 200 impulses for 12 days) increased osteogenesis by stimulating 
superoxide production both in vitro and in vivo (F. S. Wang et al., 2004). Other proposed 
mechanisms of osteogenesis mediated by ESWT include p38 MAPK pathway and activation of 
purinoreceptor 7 receptors (Sun et al., 2013). Another study demonstrated shock waves affect the 
mammalian target of rapamycin-focal adhesion kinase (mTOR-FAK) pathway in bone marrow 
MSCs (F.-Y. Lee et al., 2017). In a study using a human bone marrow MSC cell line, varied 
numbers of impulses ranging from 250 to 1000 at 0.16 mJ/mm2 were applied. At 500 impulses, 
the highest cell proliferation rate was observed with the induction of Ras and TGF-β after one 
and twenty-four hours of treatment. An upregulation of alkaline phosphatase and collagen I was 
shown by day six and osteocalcin by day 12 (F.-S. Wang et al., 2001).  
So far, studies have used varying energy flux density from 0.05-0.15 mJ per mm2 and impulses 
ranging from 100-1000 but with no consensus as to which energy level has the maximum 
biological effect. There is also little evidence as to how varying frequency could affect cellular 
signaling. Most of the studies have applied pulse frequencies between 2 and 5 Hz. This strongly 
suggests that the outcome depends on the modality of shock wave treatment, number of impulses, 
energy level, and frequency used. 
In contrast to focal ESWT, studies using rSWT at 500 impulses and 0.05 mJ/mm2 inhibited 
osteoblastogenesis in osteoblasts. They reported a reduction in collagen type 1, osteocalcin and 
NFκB ligand at 24 hours and concluded that rSWT is not useful in bone healing (Notarnicola et 
al., 2012). Tanja et al. 2013 for the first time showed differential effects of radial shock waves 
(100, 200, 500 or 5000 impulses, 2.5 bar, 1 Hz) when applied in vitro. They tested the dose-
dependent effect on human foreskin fibroblasts and choriocarcinoma that are of mesenchymal 
and epithelial origin, respectively (Hochstrasser, Frank, & Schmitz, 2016). Interestingly, cell 
proliferation remained unaffected in choriocarcinoma cells, while foreskin fibroblasts showed a 
dose-dependent increase in growth potential (Hochstrasser et al., 2016). Thus, studies using 
rSWT show that it induces mechanical damage to the cellular membrane rather than programmed 





Extracorporeal shock wave therapy has also been studied on normal fibroblasts to assess its 
suitability in hastening soft tissue repairs (Frairia & Berta, 2011). Other differentiated cells, such 
as human-derived tenocytes from ruptured tendons, show enhanced cell proliferation and 
migration when exposed to shock waves at 1000 impulses and 0.14 mJ/mm2 (Leone et al., 2012). 
Apart from the regenerative effect, it is also useful in transfecting site-specific or systemic 
delivery of genes (Ha et al., 2015). 
Overall, shock wave treatment triggers a biological response (mechanotransduction) which 
initiates the activation of specific cells such as pericytes, osteoblasts, fibroblasts, and MSCs to 
repair the bone or regenerate the damaged tissues. However, the exact mechanism of shock wave 
therapy that brings about a physiological effect needs to be further elucidated.  
2.12 LACUNAE IN THE RESEARCH (GAP-IN-KNOWLEDGE) 
Though existing strategies for treating pediatric growth disorders often are effective, the 
treatment is expensive, and long-term safety concerns exist. An alternative, effective non-
invasive approach with fewer potential side-effects is therefore highly desired. Non-invasive 
strategies such as extracorporeal shock wave therapy, ultrasound, radiofrequency ablation, and 
low-level laser therapy have been explored for their potential use to modulate bone growth. Based 
on the observed clinical effect on fracture nonunions, we hypothesized that shock wave treatment 
could be used for growth modulation. An optimized shock wave protocol will allow either 
stimulation or inhibition of bone growth in children with extremely short or tall stature, 
respectively; or to be applied unilaterally to correct leg length differences. Alternatively, a dose 
that does not affect growth could be used for treating non-skeletal disorders. Though many 
studies have been conducted, the literature still lacks in understanding the overall impact of shock 
wave treatment on linear bone growth. The results must be interpreted carefully based on the 
animal model before claiming clinical relevance of the treatment. Very few studies have reported 
the independent effect of varying impulses, energy level, and frequency in vitro while the 
therapeutic effect in a clinical setting is still unknown. Moreover, the long-term effect of ESWT, 
either focal or radial, on a growing physis remains unelucidated.  
Based on the existing literature, this thesis aimed to gain insights into the physiological 
mechanisms adopted by chondrocytes for modulation of linear bone growth following shock 
wave treatment and to determine how these specific activities are accommodated during a growth 







3 RESEARCH AIMS 
The overall main aim of the study was to investigate the effects of radial shock wave treatment 
on growth plate cartilage and longitudinal bone growth.  
More specifically, I aimed to:  
▪ Explore in vitro effects of shock wave treatment on growth plate chondrogenesis.  
▪ Study if shock wave treatment can rescue bone growth in an ex vivo model of impaired 
bone growth.  
▪ Assess the in vivo effects of shock wave treatment on bone growth and growth plate 
cartilage. 






Table 5. Models used to accomplish the aims of this thesis 
Model Species Age To investigate the effect of radial 
shock wave treatment on 
Organ culture 




Fetal day 20 of gestation Local bone growth under normal and 
diseased conditions 
In vivo New Zealand 
white rabbits 
6 weeks, 22 weeks Bone growth under systemic conditions 
In vitro cultured 
ATDC5 cells 
Mouse Chondroprogenitors Temporal regulation of chondrogenesis 
Organ culture 







































4 METHODOLOGICAL CONSIDERATIONS 
4.1 ETHICAL CONSIDERATIONS 
In this thesis, I investigated the effect of shock wave therapy, a non-invasive technique for 
modulation of longitudinal bone growth. To address whether my scientific question can add value 
to the existing research, it is indispensable to test the hypothesis using appropriate preclinical 
models. To this end, three different model systems were utilized: local and rescuing effects of 
radial shock wave treatment were tested in an ex vivo model of cultured fetal rat metatarsal bones 
(Paper I, II); systemic effects of radial shock wave treatment were studied in vivo using a rabbit 
model (Paper III), and local mechanistic effects were verified using ex vivo cultured human 
growth plate cartilage and mouse ATDC5 chondroprogenitors (Paper IV). Here, I intend to 
discuss the ethical considerations involved in my research to understand how the experiments 
conducted using animal and human samples will add value to society.  
Before I proceeded for in vivo testing, I attempted to address if my scientific purpose of the 
research is significant enough to justify the use of biological material. Furthermore, I generated 
proof-of-principle data using a fetal rat metatarsal organ culture (Paper I, II). The institutional 
review board approved this study (IRB Min. no. 8513) and institutional animal ethics committee 
(IAEC 25/2013; IAEC 10/2019) at Christian Medical College, Vellore, India and Karolinska 
Institutet: Regional animal ethics committee (Permit no. 13572-2018). I considered this model, 
keeping in mind the 3Rs (replace, reduce and refine) and I could collect many bones from the 
same animal allowing many experimental groups with a minimum number of animals sacrificed. 
This model is ideal for demonstrating an apparent change in the bone length during the treatment 
and performing subsequent histomorphometric studies. I also understood the importance of 
having a good experimental design with precise statistical analysis to reduce the number of 
animals in research. The data obtained from this model should be extrapolated with caution as 
there are several limitations built-in to the model system used, such as lack of vascularity and 
systemic factors. Furthermore, the results need to be validated in a species where growth plates 
undergo fusion during or after sexual maturation, mimicking the normal pattern of growth plate 
maturation seen in humans. 
Based on the ex vivo data, I considered performing in vivo experiments in immature rabbits 
(project 2) considering the similarity of the growth plate cartilage with that in a growing child. 
The institutional review board approved the study (Min. no. 8963) and the institutional animal 
ethics committee (IAEC 5/2014) at Christian Medical College, Vellore, India. I ensured that the 
animals were handled in a humane manner and caged individually with an adequate supply of 
water and feed; during the shock wave treatment, they were administered with appropriate 
anesthetics and analgesics. Before conducting a long-term in vivo experiment, I conducted a pilot 
study to verify the short and long-term effects on histology and final bone length, respectively. I 
understood that unlike rodents, the intraspecies variability in rabbits is much higher. Based on 
power analysis, I used 12 animals for my long-term experiments. 
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The use of human tissue samples in research is debatable. Though we conduct preclinical studies, 
there is a physiological difference between animals and humans, especially in the regulation of 
growth plate chondrogenesis. This is one of the reasons why experiments that respond well in 
preclinical studies do not necessarily translate when tested in patients. To bridge this gap and 
understand the clinical significance of this project, I obtained growth plate cartilage biopsies from 
children undergoing epiphysiodesis, a procedure to stop bone growth. The tissue that I obtained 
was removed as a part of their elective surgery without any additional procedure being 
performed. The study was approved by the institutional review board (Min. no. 11383) at 
Christian Medical College, Vellore, India. The patients’ autonomy was respected by obtaining 
informed consent from parents and child’s assent by the surgeon before the tissue harvest. The 
identity of the patients was not disclosed to any of the researchers handling the tissues in the lab. 
Patients and parents were explained that the current research using human growth plate samples 
would not have any immediate benefits for them, but the findings may lead to the development 
of a new non-invasive treatment for future patients with extreme short stature, tall stature or limb 
length discrepancy. I believe that we perform research using animal and human samples in a hope 


















4.2 EX VIVO CULTURE OF FETAL RAT METATARSAL BONES (PAPER I, II) 
Pregnant rats at the 19/20th day of gestation were euthanized, and middle-three metatarsals from 
the hind limbs of the fetuses were harvested under a dissection microscope. The bones were 
pooled and collected in Dulbecco’s Modified Eagle’s Medium (DMEM/F12) with gentamicin. 
The bones were cultured in complete medium containing 50 µg/mL ascorbic acid, 1 mM β-
glycerophosphate, 0.2% BSA, and 20 µg/mL gentamicin in a 5% CO2 incubator (Figure 4A). 
The pictures of bones in culture were taken, and the culture medium was replenished every two 
days. The day of dissection was identified as day 0 in culture (Paper I). 
To mimic a transient and permanent growth impairment (Paper II), metatarsal bones were 
exposed to GANT61 (St. Louis, Missouri, United States; 10 µM) and vismodegib (Selleckchem, 
Houston, Texas, USA; 100 nM), respectively (Figure 4B). 
 
Figure 4. Schematic illustration of the experimental setting for cultured fetal rat metatarsal bones 
exposed to rSWT under A. Normal physiological condition or B. Growth impaired condition.         




4.2.1 Radial shock wave treatment 
All experiments in this thesis were carried out using Radial Spec., Medi Spec., (Gaithersburg, 
MD. USA). The penetration depth of the radial pressure waves is 2 cm from the superficial 
surface. The 15-mm applicator probe was placed on top of the tube with ultrasound gel to avoid 
scattering of the waves. The radial shock wave machine used in the study is shown in Figure 5. 
For radial shock wave treatment, the bones were placed in a 1.5 ml Eppendorf tube with a 
complete medium. After exposure to the respective rSWT session, the bones were transferred 
back into a 24-well culture plate and followed for 14-15 days. The high-energy rSWT used in 
this experiment was 500 impulses, 10 Hz, 180 mJ. 
  
Figure 5. A radial shock wave machine from Medispec, Gaithersburg, USA 
4.2.2 Bone length measurements 
The longitudinal bone growth was measured by using an inbuilt measurement tool in Leica 
microsystem software on day 0, 2, 4, 7, 9, 12, and 14, 15.  
4.2.3 Histology, histomorphometry and immunostaining 
Five-micrometer longitudinal sections of the bones were stained with Alcian blue and Safranin-
O for visualizing the cartilaginous structure. Based on the cell morphology, the height of the 
resting+ proliferative zone and the hypertrophic zone were performed. The hypertrophic cell size 







4.3 IN VIVO STUDIES IN A RABBIT MODEL (PAPER III) 
The temporal effects of rSWT were investigated in healthy immature, and adolescent rabbits 
(Figure 6).  
4.3.1 Pilot study (histological study) 
Six-week-old New Zealand white rabbits weighing 0.9-1 kg were divided into two groups (n=4 
each). All animals were anaesthetized given an intramuscular injection of ketamine (22 mg/kg) 
and xylazine (2.5 mg/kg) cocktail before treatment. The right hind limb of the animal received 
the shock wave treatment while the left hind limb was untreated and acted as a control. Each 
animal received a low-energy dose of 1500 impulses, 5Hz, 90 mJ and a high-energy dose of 3000 
impulses, 10 Hz, 180 mJ. The treatment was administered four times (at one-week intervals). 
After six weeks of follow up, all animals were sacrificed by intraperitoneal Pentothal Sodium 
injection (5 mg/kg). 
4.3.2 Longitudinal bone growth study 
A total of twelve 22-week-old rabbits were treated with radial shock waves (3000 impulses, 5 
Hz, 180 mJ) four times at an interval of 1-week. The animals were further followed up for seven 
weeks after the last treatment. Bone length measurements were performed on the harvested tibia 
at the end of the sacrifice.  
 
Figure 6. Experimental overview of in vivo rabbit studies. A histological pilot study was conducted in 




4.4 EX VIVO CULTURE OF HUMAN GROWTH PLATE CARTILAGE (PAPER IV) 
To study the response on a model that is closest to the human scenario, we used human growth 
plate cartilage specimens. We obtained the human growth plate cartilage from patients 
undergoing surgery for epiphyseal drilling to restrict the bone growth in patients with leg length 
differences. The growth plate cartilage biopsies were collected using a biopsy needle (Gallini 
Biomid, size 7G 10cm, Apgar, Denmark). The obtained biopsies were transferred to a tube 
containing DMEM-high glucose and 20 µg/ml gentamicin. During culture, medium was 
supplemented with ascorbic acid (50 µg/ml), beta glycerophosphate (1mM), 0.2% BSA and kept 
in 37ºC with 5% CO2 incubator. Following incubation, samples were treated with radial shock 
waves (500 impulses, 180 mJ, 5 Hz) and cultured for another 48 hours in 37ºC with 5% CO2 
incubator. Samples were washed in 1x PBS and kept at -80°C for RNA isolation and gene 
expression analysis for chondrogenic genes: SOX9, GLI1, IHH, COLX, and IGF1 were 
performed using RT² Profiler PCR Array kit (Qiagen, Germany) (Figure 7A).  
4.5 MOUSE ATDC5 CHONDROPROGENITOR CELLS (PAPER IV) 
The ATDC5 chondrogenic clonal cell line derived from mouse embryonic carcinoma AT 805 
cells were used in this study.  Cells at a density of 5000 per cm2 were plated in a T75 cm2 flask 
and cultured in DMEM/F12 containing 5% fetal bovine serum, 1% insulin transferrin selenium, 
1% sodium pyruvate and 0.5% gentamicin. At 80% confluence, cells were detached and exposed 
to 500 impulses, 10 Hz, 180 mJ of radial shock waves in a 1.5 ml Eppendorf tube containing the 
culture media. A total of 1 million cells were placed per tube. The experiment was repeated thrice 
with three replicates each. Gene expression was assessed at 0, 30 mins, 1.5, 3 and 14 hours after 
rSWT using q-PCR. Fold change for Aggrecan (Acan), Collagen 2 (Col2a1), Sox9, alkaline 
phosphatase (Alpl), and Runx2 gene expression were assessed and normalized to beta-actin (Actb, 
housekeeping gene). The experimental overview is given in Figure 7B. Fold change was 




Figure 7. Experimental overview of the in vitro studies conducted using A. Spatial effects of rSWT 
on human growth plate cartilage (1. Procedure to obtain growth plate cartilage, 2. Gross bits of the growth 
plate cartilage discs, 3. Exposure of growth plate cartilage to rSWT and culture, 4. Gene expression 
analysis using real-time PCR). B. Temporal effects of rSWT on mouse ATDC5 chondroprogenitor cells 
(1. Exposure of ATDC5 cells to rSWT and 2. Gene expression analysis using real-time PCR).  
4.6 STATISTICAL ANALYSIS 
All statistical analyses were carried out using GraphPad Prism 8.0 (GraphPad Software, Inc, La 
Jolla, CA, USA). Data, when normally distributed, were represented as means ± SD for the bone 
length measurements and growth plate histomorphometric assessments. Kruskal–Wallis and 
Mann–Whitney U test was used for data that were not normally disturbed (Paper I, II). For 
comparison between two groups, an appropriate t-test was applied after checking for normal 
distribution; paired t-test was applied for comparison of final bone length (Paper III). For gene 
expression analysis (human growth plate study), Mann-Whitney U test was performed, and for 
ATDC5 study, Student's paired t-test was performed (Paper IV). Probability values < 0.05 


































5.1 EX VIVO AND IN VIVO EFFECTS OF RADIAL SHOCK WAVE TREATMENT  
We addressed whether radial shock wave treatment improves longitudinal bone growth using 
two different model systems. An ex vivo model of fetal rat metatarsal that is devoid of vascular 
and growth factors (Paper I) and in vivo model of healthy New Zealand white rabbits with 
circulating systemic factors (Paper III). Below is the summary of key findings obtained in the 
two different models. 
5.1.1 Gross  
Our proof-of-principle study from fetal rat metatarsal culture experiments demonstrated that a 
single application of high-energy radial shock wave treatment could stimulate longitudinal bone 
growth in the absence of any circulating growth factors (Paper I). We then verified this effect in 
vivo by exposing adolescent rabbits to four weekly-sessions of high-energy rSWT. At skeletal 
maturity, a change in the final bone length was observed (Paper III). Our data, therefore, suggest 
that radial shock wave treatment contributes to overall increased linear bone growth.  
5.1.2 Microscopic  
To investigate the microscopic changes in growth plate cartilage, a histomorphometric analysis 
was performed. Cultured metatarsal bones exposed to high-energy rSWT stained with Alcian 
blue demonstrated a significant change in the size of the hypertrophic chondrocytes compared to 
untreated control. This was further supported by an increase in the COLX immunostaining 
(paper I). In contrast, growth plate sections from rabbits treated in vivo with high-energy rSWT 
revealed no change in chondrocyte hypertrophy, although one animal showed increased bone 
formation at the site of treatment (Paper III). 
5.1.3 Radial shock wave treatment triggers cellular and molecular changes on 
the growth plate cartilage 
To determine the occurrence and location of proliferative cells, metatarsal sections exposed to 
high-energy rSWT, were stained for PCNA, a marker for proliferating cells. As anticipated, = 
proliferative zone chondrocytes showed a high prevalence of PCNA positive cells throughout the 
growth plate compared to untreated control (Paper I). In the rSWT treated rabbit growth plate 
sections, along with an increased number of proliferative chondrocytes, the number of 
chondrocyte columns per mm width of the growth plate section was also increased (Paper III). 
In both the models, we found no change in cell death as determined by TUNEL assay after rSWT 
treatment. These data indicate that rSWT exerts mitogenic effects in growth plate chondrocytes 




We investigated the molecular mechanism behind the observed stimulatory effects of high-
energy rSWT treatment by looking for various local growth factors that contribute to long bone 
growth. We found increased expression of Pthrp/Gli1 signaling in the rSWT treated metatarsal 
bones. The expression of Pthrp and Gli1 was localized mainly in the resting and proliferating 
zone. BCl2 and BClx, the downstream targets of PTHrP, were also increased. Besides, 
downstream master transcription targets of bone growth, NF-ĸB was also upregulated throughout 
the growth plate cartilage compared to untreated control. We also found evidence of increased 
Igf1 levels, supporting our histomorphometric findings. These observations show that high-
energy rSWT can stimulate local upregulation of molecular growth factors responsible for 
growth plate chondrogenesis. Since the presence of vascularity is a significant factor in 
endochondral ossification but lacks in the metatarsal organ culture model, we assessed the fetal 
liver kinase-1 expression, a receptor for vascular endothelial growth factor (VEGF) which was 
enhanced after high-energy rSWT compared to untreated control. Similarly, rabbits treated with 
rSWT demonstrated a trend increase in the serum VEGF levels. 
Overall, the findings from the ex vivo (Paper I) and in vivo studies (Paper II) suggest that rSWT 
can stimulate longitudinal bone growth and growth plate chondrogenesis under normal 
physiological conditions (Figure 8).  
 
Figure 8. Radial shock wave treatment positively regulates growth plate chondrogenesis in cultured 
rat metatarsal bones and in vivo in rabbits. The progression towards linear bone growth by chondrocyte 






5.2 CHONDRO-PROTECTIVE (EX VIVO) EFFECTS OF RADIAL SHOCK WAVE 
TREATMENT UNDER IMPAIRED BONE GROWTH (PAPER II) 
Most of the children present with growth disturbance in the clinics do not have a healthy growth 
plate. The data from the first set of experiments performed under normal physiological 
conditions, although provided us with a lead, may not be relevant in this case. To understand if 
radial shock wave treatment can rescue bone growth in a model of growth failure, we blocked 
local growth factors. Based on the knowledge we obtained from our previous study, we targeted 
the hedgehog signaling pathway to induce bone growth impairment in ex vivo cultured metatarsal 
bones (Paper II). Two different small molecule inhibitors that impair hedgehog signaling at 
different levels were used (Figure 9).    
 
Figure 9. Canonical activation of the HH/GLI signaling pathway. In the absence of HH ligand patched 
(PTCH) inhibits Smoothened (SMO) and the signaling complex SUFU/GLI undergoes phosphorylation 
to cleave GLI1. The truncated GLI translocates into the nucleus where they inhibit transcription of 
hedgehog target genes. Upon HH ligand binding (right) the SMO promotes translocation of full-length 
GLI in active form into the nucleus to activate the transcription of target HH genes. Vismodegib impairs 
bone growth by blocking SMO (upstream) while GANT61 blocks the transcription of HH target genes 




5.2.1 Rescuing effects of radial shock wave treatment in ex vivo cultured 
metatarsal bones 
To understand if the stimulatory effect of shock waves could be achieved in a condition of growth 
failure, metatarsal bones were exposed to two different Indian hedgehog inhibitors, vismodegib 
and GLI antagonist (GANT61). Vismodegib binds to Smoothened, a transmembrane protein 
involved in Hedgehog signal transduction (Gli1/2 inhibited). We specifically chose this small 
molecule as it is being used in the clinics to treat children with medulloblastoma. During the 
study period, a paper in Oncotargets was published, which showed that vismodegib caused 
irreversible growth plate fusion in children as a side effect (Robinson et al., 2017). This motivated 
us to carry out a proof of principle study in metatarsal bones somewhat to mimic the impaired 
growth plate chondrogenesis in children. GANT61 on the other inhibits transcription of GLI and 
acts downstream to Hh signaling. This drug is under preclinical investigation and has not been 
used to study its effects on longitudinal bone growth.  
5.2.2 Bone growth and histomorphometry 
To induce transient growth impairment, bones were treated with vismodegib for five days and 
followed for another ten days in culture. A gradual decline in bone length was observed in the 
vismodegib treated group compared to untreated control. In contrast, GANT61 was 
supplemented throughout the culture to recreate an ongoing growth impairment. The decline in 
growth was observed as early as day 4. A one-time treatment with rSWT rescued the bone growth 
from both the inhibitors.  
When evaluating growth plate morphology, bones treated with vismodegib and GANT61 
revealed disrupted columnar organization compared to their respective untreated controls. The 
ultrastructure of the growth plate was restored and almost near-normal in the bones co-treated 
with rSWT. A more pronounced reduction in the hypertrophic cell size was observed in both the 
inhibitor-treated groups, and this was overcome in bones that received rSWT along with the 
inhibitors. Mechanistic studies for Gli-1 (Figure 10) and Ihh revealed a trend increase in the 
expression of these markers with or without inhibitor treatment. 
 
Figure 10. Restoration of GLI1 expression after rSWT. Figures show GLI1 immunostaining in control, 
GANT61 treated, rSWT treated, and rSWT+ GANT61 treated metatarsal bones. Note the partial 




5.3 MOLECULAR MECHANISM OF RADIAL SHOCK WAVE TREATMENT ON 
HUMAN GROWTH PLATE TISSUE AND MOUSE ATDC5 
CHONDROPROGENITORS 
To verify our promising preclinical data in cultured fetal rat metatarsal bones and in vivo in 
rabbits, we extended our study to rare samples of human growth plate cartilage cultured ex vivo 
and exposed to rSWT. A pilot study was first conducted to explore the effects of rSWT on 
chondrogenic markers, and then a more detailed molecular analysis was performed to see how 
shock waves affect various growth plate zones (Paper IV).  
5.3.1 Pilot study - Chondrogenic markers after rSWT 
Gene expression analysis for SOX9 and COL2A1 was performed at 24-hours after exposure of 
human growth plate tissues to high-energy rSWT. Since each patient has their basal level 
expression of gene markers, it was worthwhile to analyze the data by separating them as 
responders and non-responders to the treatment. We, therefore, decided to individually present 
the trend increase in gene expression in different patients. An increased expression of SOX9 and 
COL2A1 was found when compared to untreated controls. Three out of the five patient samples 
showed a mild increase in gene expression, while the other two samples showed a pronounced 
effect (Paper III).  
5.3.2 Spatial regulation of gene expression after rSWT 
Based on this lead, we studied the effect of rSWT on spatial gene expression of local molecular 
factors marking different growth plate zones responsible for proliferation and hypertrophy SOX9, 
GLI1, IHH, COLX, and IGF1 in five human growth plate tissues. Three different patient samples 
showed an increase in SOX9 and GLI1, while four showed an increase in IHH and COLX after 
treatment. One of the patients showed an increase in IGF1 levels (Paper IV). 
5.3.3 Temporal regulation of gene expression after rSWT 
A parallel study was conducted in mouse ATDC5 chondroprogenitor cells to investigate the 
temporal effects on growth plate chondrogenesis. The expression of Acan and Sox9 showed 
expression at 3-4 hours after rSWT. The Col2a1 levels increased at 4 hours showed a sustained 








Many of the drugs used in the pediatric population have adverse off-target effects on growth 
plate chondrocytes, e.g., glucocorticoids (Simon, Fernando, Czernichow, & Prieur, 2002), 
inflammatory cytokines (Sederquist, Fernandez-Vojvodich, Zaman, & Sävendahl, 2014), and 
chemotherapy (Eriksson et al., 2012). Several strategies have been investigated in the past for 
the modulation of bone growth, and some of them are listed in the tables below (Table 6, 7). 
Herein, our data shows that a single session of rSWT improves longitudinal bone growth in ex 
vivo metatarsal cultures and in vivo in rabbits, a consequence linked to augmented proliferation 
and decreased apoptosis of growth plate chondrocytes. The effect observed ex vivo was 
mediated by upregulation of local growth factors governing longitudinal bone growth. We also 
show that rSWT rescues the bone length and protects growth plate chondrocytes when there is 
transient growth failure. Furthermore, the chondrogenic effect of rSWT on human growth plate 
cartilage was confirmed, where different local molecular factors in each growth plate zone were 
upregulated. Altogether, the present study focused on delineating how growth plate 
chondrogenesis and thereby longitudinal bone growth are affected by radial shock wave 
treatment.      
Table 6. Models investigated for growth plate stimulation 
Method to create growth stimulation 
Model Molecules Reference(s) 
Socs2‐/‐ pups GH, IGF‐1  (Dobie et al., 2015; Mancilla, De 
Luca, Uyeda, Czerwiec, & Baron, 
1998)  
E19 IGF-1, PTH (Coxam, Miller, Bowman, Qi, & 
Miller, 1995) 
E20 Resveratrol (Karimian et al., 2013) 
E20 HNG (Zaman et al., 2019) 
E20     Radial shock wave treatment (Ramesh, Zaman, et al., 2020) 
E20 Lithium Chloride (Soucek, Zaman, & Sävendahl, 2015) 
Method to create growth stimulation 
Model Molecules Reference(s) 
Igf1 null mice Genetic knockout (J. Wang, Zhou, & Bondy, 1999) 
Neonatal Rat bones Fluoride (Ma et al., 2019) 
E20 bones FGF2 (Mancilla et al., 1998) 
E20 and P8 bones Dexamethasone (Chagin, Karimian, Sundström, Eriksson, 
& Sävendahl, 2010) 
E20 bones IL‐1β, TNF‐α (Mårtensson, Chrysis, & Sävendahl, 2004) 
E20 bones Bortezomib (Eriksson et al., 2012) 
E20 bones Letrozole (Chagin, Chrysis, Takigawa, Ritzen, & 
Sävendahl, 2006) 





Longitudinal bone growth depends majorly on the synchronized activities of chondrocytes 
within the physeal cartilage, and therefore the rate at which proliferation and differentiation 
occur will reflect in one or more measurable parameters defining chondrogenesis (Emons et 
al., 2011; E. B. Hunziker, 1994). The metatarsal model used in this study allows for the study 
of linear bone growth. There is considerable evidence that suggests the influence of 
biomechanical stimulus in the process of longitudinal bone growth, where more pressure on 
the growth plate delays bone growth and reduced pressure stimulates growth (Villemure & 
Stokes, 2009). We also observed that shock wave treatment, a form of mechanotherapy 
stimulated linear bone growth in ex vivo cultured metatarsal bones, suggesting that these bones 
experienced a reduced pressure (Ramesh, Zaman, et al., 2020). Furthermore, when tested in 
vivo in adolescent rabbits, an increase in tibial length was found. One would postulate that the 
high-energy dose to be deleterious to chondrocytes, but these findings highlight that a higher 
dose need not necessarily harm the cells but rather be physiologically beneficial as well. The 
mechanisms behind the observed stimulation of growth could be envisaged to follow one or a 
combination of the many proposed sequences.  
The cellular response to mechanical signals contributing to the accelerated growth can be 
evaluated using growth plate histomorphometry. During embryonic development, longitudinal 
bone growth has three primary components: chondrocyte proliferation, hypertrophy, and 
cartilage matrix synthesis. Following shock wave treatment, increased cell proliferation was 
observed in both ex vivo cultured metatarsal bones (Paper I) and treated rabbit growth plate 
cartilage (Paper III). Based on these observations, it can be speculated that the stimulation of 
the resting chondrocytes  subsequently amplifies the generation of daughter cells during their 
recruitment into the proliferative zone, leading to a clonal expansion effect (Figure 11) (E. B. 
Hunziker, 1994). Growth hormone is one such agent capable of producing a differentiation 






Figure 11. A schematic representation of rSWT mediated effects on chondrocyte proliferation 
and hypertrophy under normal and growth impaired conditions. A. Normal chondrocyte division 
B. Accelerated cell division after rSWT, C. Impaired cell division in the presence of hedgehog 
inhibitors, D. Chondroprotective effect of rSWT in the presence of inhibitors.  
Chondrocyte hypertrophy is another essential regulator of linear bone growth (E. Hunziker & 
Schenk, 1989). Radial shock wave treatment showed a pronounced hypertrophic effect on the 
metatarsal bones. This could not be verified in vivo in rabbits, probably due to their differences 
in the growth plate mitotic activity across species. Most of the reports advocate that 
hypertrophic chondrocytes significantly contribute to bone growth under mechanical stimulus, 
just like during the normal regulation of growth. This indeed is interesting as one would 
presume that the change in the proliferative columns primarily modulates the growth. 
However, studies suggest that the hypertrophic zone, being the least rigid region of the growth 
plate and sensitive to the maximum deformations under mechanical loading, is considered 
mechanotransduction zone (Villemure & Stokes, 2009). This is probably due to their swollen 
lacunae. When compression is applied to the growth plate, it reduces the hypertrophic zone 
thickness and chondrocyte volume with reduced expression of ECM proteins (type II and X). 
Thus, it is likely that metatarsal growth plate in response to an external mechanical distraction 
force led to an increase in the increased matrix synthesis, change in tissue and cell morphology, 
contributing to an overall increase in bone length. Several signaling pathways have been 
known to play critical roles in influencing growth plate cellular activities (Lui et al., 2010). In 
this study, we found a causal relationship behind the observed increase in linear bone growth 
via upregulation of the following local growth factors that are proliferative and/or anti-
apoptotic: PTHrP/GLI1, NFkB, IGF1, BCL2, Bcl-X. We speculate that following shock wave 
treatment there was a direct stimulation of the cell nuclei that are involved in the transcription 




A previous in vivo study in rabbits demonstrated an increase in physeal thickness, six weeks 
after three sessions of lithotripsy with no change in bone length (Ozturk et al., 2008). This is in 
line with our study, where we also observed a trend of increasing physeal thickness in an 
immature rabbit model six weeks after rSWT with no effect on limb length. In the subsequent 
experiments, we used the same methodology and followed up the animals until growth plate 
fusion and found no change in bone length. We learned that the in vivo effects of rSWT are 
very transient, and a continuous exposure to rSWT would be required for sustained effects on 
bone growth. We also learned from our in vivo experiments that it is difficult to override the 
intrinsic growth plate memory to alter the bone length by applying a transient treatment. 
Alternatively, one could postulate that the low-energy dose used in this study could not affect 
growth and thereby considered a safe dose for non-skeletal disorder and applied around the 
physis. 
Based on these leads, in the next set of experiments, we exposed adolescent rabbits to high-
energy rSWT. We then saw an increase in tibial length in these animals. This in line with the 
only study published so far by Saisu et al., where focal shock wave treatment stimulated final 
bone length in rabbits (Saisu et al., 2004). From our in vivo studies, we learned that systemic 
factors would try to compensate for minor changes in the bone length, which is easier to 
observe in species like rodents owing to their increased cellular activity. We did not present 
any convincing evidence that these models have any relevance to children with growth 
disturbances. Therefore, we speculated that by creating an adverse environment for the cells to 
proliferate using an ex vivo metatarsal model, the subsequent effect of rSWT on cell 
morphology and phenotype would be easier to assess.  
Clinical use of vismodegib in children with pediatric brain tumors, has a destructive effect on 
growth plate chondrocytes (Robinson et al., 2017). To date, no effective treatment is available 
to protect these bones. An extension study to our preliminary findings, we created a model of 
impaired bone growth to test if shock wave treatment could reverse these detrimental effects. 
To understand the physiological role of rSWT during impaired growth plate chondrogenesis, 
we blocked the hedgehog signaling pathway that has a role in chondrocytes proliferation and 
differentiation using two antagonists, vismodegib and GANT61. The inhibitors disturbed 
chondrocyte proliferation and hypertrophic differentiation, leading to a decreased bone length 
(Paper II). These data are in line with the recent clinical observation where vismodegib has 
been reported to cause permanent growth plate fusion in children. While when treated with 
rSWT, we found that despite the presence of the inhibitors, priming the bones with rSWT 
stimulated an intrinsic mechanism to partially protect the cells from the damage; resulting in 






The exact mechanism underlying the chondroprotective effect of rSWT remains unclear and 
requires further investigations. It is indeed interesting to study how mechanical waves can 
modulate the molecular activity in growth plate chondrocytes and have long-term effects on 
chondrogenesis and longitudinal bone growth. The mechanisms through which these local 
signals are translated into gene expression have never been investigated in the human growth 
plate. Therefore, we corroborated our findings in cultured human growth plate tissue from 
prepubertal children and found increased expression of genes associated with chondrogenesis 
further strengthening our preclinical findings. To our knowledge, we are the first to 
demonstrate the spatial effects of rSWT on different growth plate zones in an ex vivo model of 
cultured human growth plate cartilage where different genes where chondrogenic genes were 
enhanced in different patients. Besides, we also explored the temporal regulation of rSWT 
using mouse ATDC5 chondroprogenitor cells where genes responsible for matrix synthesis 
were upregulated (Paper IV). These findings supported that there is increased matrix 
production following mechanotherapy. 
6.1 LIMITATIONS  
This study has several limitations, and the reader should interpret our main findings in light 
of each limitation Firstly, the ex vivo model of cultured metatarsals  allowed us to investigate 
the local effects but not the endochondral ossification as it lacks vascularity (Paper I, II). 
Secondly, we did not test the efficacy of multiple sessions of rSWT on growth plate 
chondrogenesis. This would have given us more information on when to administer the 
subsequent shock wave treatment.  Thirdly, we used very few patient samples in the human 
growth plate experiments, and each patient had a different response in gene expression 
pattern (Paper IV). This could be due to the inherent biological heterogeneity. Finally, the 
effect of rSWT on primary cilia was not characterized in this study. This would have given us 














Our findings suggest that radial shock wave treatment positively regulates longitudinal bone 
growth:  
1) Radial shock wave treatment enhances chondrocyte proliferation and hypertrophy by 
increasing the NFkB/Gli1 signaling pathways in cultured rat metatarsal bones;  
2) Radial shock wave treatment stimulates growth plate chondrogenesis and longitudinal bone 
growth in young and adolescent rabbits;  
3) Radial shock wave treatment protects bone growth and growth plate chondrocytes under 
conditions of impaired bone growth involving suppressed Hh signaling; 
4) Radial shock wave treatment upregulates genes modulating distinct zones of proliferation 
and hypertrophy in cultured human growth plate cartilage 
These findings provide new knowledge and opportunities for a better understanding of the 
molecular and cellular mechanisms by which mechanotherapy aids in accelerating bone growth 
and growth plate chondrogenesis. 
 
Figure 12. A schematic summary of data obtained in 1. Mouse chondrocytes, 2. Ex vivo cultured rat 
metatarsal bones, 3. In vivo in rabbits, and 4. Ex vivo cultured human growth plate cartilage. Molecular 
markers increased after rSWT are detailed in the diagram.  
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8 POINTS OF PERSPECTIVE 
Over the last few decades, our understanding of the structural, cellular, paracrine and endocrine 
regulation of longitudinal bone growth at the growth plate level has substantially advanced. In 
this thesis, I have focused on recent advances in the understanding of growth plate biology and 
treatment of growth failure.  
The findings from the current thesis have identified important biological mechanisms and many 
molecular targets regulating longitudinal bone growth following radial shock wave treatment. 
These may eventually lead to a promising potential new treatment for growth failure that is 
currently being evaluated in preclinical studies. However, like every research, our study yields 
more questions than it answers.  
For example, i) can radial shock wave treatment rescue impaired bone growth in vivo?; ii) 
which intrinsic mechanotransduction signals are activated?; iii) what happens when 
continuously exposing to shock wave treatment in the presence of systemic hormones and 
circulating growth factors, will it be synergistic or will they nullify each other? 
In the future, regulating the signaling cascades by which shock waves promote linear bone 
growth may develop as a new evolving strategy for growth plate deformities, and I am happy 
that the findings from this thesis would have laid the foundation for future research in growth 
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